88 related articles for article (PubMed ID: 12717521)
1. Cystatin C and cysteine proteinases during the development and therapy of Lewis lung adenocarcinoma in mice.
Usova TA; Poteryaeva ON; Zhanayeva SY; Yarygina ES; Korolenko TA
Bull Exp Biol Med; 2003 Jan; 135(1):81-4. PubMed ID: 12717521
[TBL] [Abstract][Full Text] [Related]
2. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma.
Poteryaeva ON; Falameeva OV; Zhanaeva SY; Svechnikova IG; Korolenko TA; Kaledin VI
Bull Exp Biol Med; 2001 Jul; 132(1):675-7. PubMed ID: 11687851
[TBL] [Abstract][Full Text] [Related]
3. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Stimulator beta-(1-->3)-D-carboxymethylglucan improves the efficiency of chemotherapy of Lewis lung carcinoma.
Falameeva OV; Poteryaeva ON; Zhanaeva SY; Levina OA; Filatova TG; Korolenko TA; Kaledin VI; Sandula I; Kogan G
Bull Exp Biol Med; 2001 Aug; 132(2):787-90. PubMed ID: 11713568
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.
Keyszer G; Lambiri I; Keysser M; Keysser C; Nagel R; Burmester GR; Jung K
Z Rheumatol; 1998 Dec; 57(6):392-8. PubMed ID: 10025098
[TBL] [Abstract][Full Text] [Related]
6. Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera.
Cimerman N; Brguljan PM; Krasovec M; Suskovic S; Kos J
Clin Chim Acta; 1999 Apr; 282(1-2):211-8. PubMed ID: 10340450
[No Abstract] [Full Text] [Related]
7. [Prognostic significance of lysosomal cysteine proteases in the estimation of the effectiveness of the antitumorigenic therapy].
Zhanaeva SIa; D'iakov AI; Alekseenko TA; Korolenko TA
Biomed Khim; 2009; 55(1):89-97. PubMed ID: 19351038
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
[TBL] [Abstract][Full Text] [Related]
9. [Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy].
Poteriaeva ON; Korolenko TA; Svechnikova IG; Zhanaeva SIa; Falameeva OV; Kaledin VI; Nowicky JW
Biomed Khim; 2004; 50(2):172-9. PubMed ID: 15179824
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.
Cimerman N; Mesko Brguljan P; Krasovec M; Suskovic S; Kos J
Clin Chim Acta; 2001 Aug; 310(2):113-22. PubMed ID: 11498076
[TBL] [Abstract][Full Text] [Related]
11. Cathepsins B and L are markers for clinically invasive types of meningiomas.
Strojnik T; Zidanik B; Kos J; Lah TT
Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
[TBL] [Abstract][Full Text] [Related]
13. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.
Decock J; Obermajer N; Vozelj S; Hendrickx W; Paridaens R; Kos J
Int J Biol Markers; 2008; 23(3):161-8. PubMed ID: 18949742
[TBL] [Abstract][Full Text] [Related]
15. Cystein proteinase inhibitor stefin A as an indicator of efficiency of tumor treatment in mice.
Korolenko TA; Poteryaeva ON; Falameeva OV; Levina OA
Bull Exp Biol Med; 2003 Jul; 136(1):46-8. PubMed ID: 14534608
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis.
Nagai A; Terashima M; Harada T; Shimode K; Takeuchi H; Murakawa Y; Nagasaki M; Nakano A; Kobayashi S
Clin Chim Acta; 2003 Mar; 329(1-2):53-60. PubMed ID: 12589965
[TBL] [Abstract][Full Text] [Related]
17. Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat.
Schaefer L; Han X; Gretz N; Schaefer RM
Kidney Int; 1996 Aug; 50(2):424-31. PubMed ID: 8840269
[TBL] [Abstract][Full Text] [Related]
18. Activities of serum cathepsin (B, H and L) and metalloproteinase (MMP7-ase) in patients with gastrointestinal and bronchial malignant tumours.
László A; Sohár I; Karácsonyi S; Petri A; Troján I
Acta Med Hung; 1990; 47(1-2):107-9. PubMed ID: 2280991
[TBL] [Abstract][Full Text] [Related]
19. Induced expression of cathepsins and cystatin C in a murine model of demyelination.
Ma J; Tanaka KF; Yamada G; Ikenaka K
Neurochem Res; 2007 Feb; 32(2):311-20. PubMed ID: 17086443
[TBL] [Abstract][Full Text] [Related]
20. Mouse lymphosarcomas sensitive and resistant to cyclophosphamide therapy: activity of cathepsins B, L, and D during various schemes of treatment with cyclophosphamide and SE-glycan.
Usova TA; Zhanaeva SY; Kogan G; Shandula I; Korolenko TA
Bull Exp Biol Med; 2003 Nov; 136(5):451-4. PubMed ID: 14968157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
